LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein

The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essenti...

Full description

Bibliographic Details
Main Authors: Jarrod Shilts, Thomas W. M. Crozier, Ana Teixeira-Silva, Ildar Gabaev, Pehuén Pereyra Gerber, Edward J. D. Greenwood, Samuel James Watson, Brian M. Ortmann, Christian M. Gawden-Bone, Tekle Pauzaite, Markus Hoffmann, James A. Nathan, Stefan Pöhlmann, Nicholas J. Matheson, Paul J. Lehner, Gavin J. Wright
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-02-01
Series:PLoS Biology
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897555/?tool=EBI
_version_ 1811170953817751552
author Jarrod Shilts
Thomas W. M. Crozier
Ana Teixeira-Silva
Ildar Gabaev
Pehuén Pereyra Gerber
Edward J. D. Greenwood
Samuel James Watson
Brian M. Ortmann
Christian M. Gawden-Bone
Tekle Pauzaite
Markus Hoffmann
James A. Nathan
Stefan Pöhlmann
Nicholas J. Matheson
Paul J. Lehner
Gavin J. Wright
author_facet Jarrod Shilts
Thomas W. M. Crozier
Ana Teixeira-Silva
Ildar Gabaev
Pehuén Pereyra Gerber
Edward J. D. Greenwood
Samuel James Watson
Brian M. Ortmann
Christian M. Gawden-Bone
Tekle Pauzaite
Markus Hoffmann
James A. Nathan
Stefan Pöhlmann
Nicholas J. Matheson
Paul J. Lehner
Gavin J. Wright
author_sort Jarrod Shilts
collection DOAJ
description The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19. A systematic search for human proteins that can bind to the spike protein of SARS-CoV-2 reveals that LRRC15 can act as a host factor for the virus, and may therefore modulate infection with potential implications for COVID-19.
first_indexed 2024-04-10T17:05:23Z
format Article
id doaj.art-90f98ee96aff4b489c474fa416cf8b43
institution Directory Open Access Journal
issn 1544-9173
1545-7885
language English
last_indexed 2024-04-10T17:05:23Z
publishDate 2023-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Biology
spelling doaj.art-90f98ee96aff4b489c474fa416cf8b432023-02-06T05:30:38ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852023-02-01212LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike proteinJarrod ShiltsThomas W. M. CrozierAna Teixeira-SilvaIldar GabaevPehuén Pereyra GerberEdward J. D. GreenwoodSamuel James WatsonBrian M. OrtmannChristian M. Gawden-BoneTekle PauzaiteMarkus HoffmannJames A. NathanStefan PöhlmannNicholas J. MathesonPaul J. LehnerGavin J. WrightThe interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19. A systematic search for human proteins that can bind to the spike protein of SARS-CoV-2 reveals that LRRC15 can act as a host factor for the virus, and may therefore modulate infection with potential implications for COVID-19.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897555/?tool=EBI
spellingShingle Jarrod Shilts
Thomas W. M. Crozier
Ana Teixeira-Silva
Ildar Gabaev
Pehuén Pereyra Gerber
Edward J. D. Greenwood
Samuel James Watson
Brian M. Ortmann
Christian M. Gawden-Bone
Tekle Pauzaite
Markus Hoffmann
James A. Nathan
Stefan Pöhlmann
Nicholas J. Matheson
Paul J. Lehner
Gavin J. Wright
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
PLoS Biology
title LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
title_full LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
title_fullStr LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
title_full_unstemmed LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
title_short LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
title_sort lrrc15 mediates an accessory interaction with the sars cov 2 spike protein
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897555/?tool=EBI
work_keys_str_mv AT jarrodshilts lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT thomaswmcrozier lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT anateixeirasilva lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT ildargabaev lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT pehuenpereyragerber lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT edwardjdgreenwood lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT samueljameswatson lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT brianmortmann lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT christianmgawdenbone lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT teklepauzaite lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT markushoffmann lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT jamesanathan lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT stefanpohlmann lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT nicholasjmatheson lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT pauljlehner lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein
AT gavinjwright lrrc15mediatesanaccessoryinteractionwiththesarscov2spikeprotein